Wealth Alliance Advisory Group’s Journey Medical DERM Stock Holding History
Bought
Maintained
Sold
Other funds holding DERM
BRF
PCM
AFG
NCM
BJL
BRWA
Wealth Alliance Advisory Group's DERM Position: Q2 2023 in Review
Wealth Alliance Advisory Group sold out of Journey Medical (DERM) in Q2 2023, closing a stake of 10,748 shares — an estimated $16.9K sold.
Wealth Alliance Advisory Group first reported a position in DERM in Q3 2022 and held it in 3 quarters. The position peaked at $53K in Q3 2022. 20 funds tracked by Wall St. Rank hold DERM as of Q2 2023.
- Wealth Alliance Advisory Group reported no remaining Journey Medical position as of Q2 2023 after selling out during the quarter.
- Wealth Alliance Advisory Group sold 10,748 Journey Medical shares in Q2 2023, an estimated $16.9K.
- Wealth Alliance Advisory Group first reported a position in Journey Medical in Q3 2022 and held it in 3 quarters.
- Wealth Alliance Advisory Group's Journey Medical position peaked at $53K in Q3 2022.
- 20 funds tracked by Wall St. Rank held Journey Medical as of Q2 2023.
Based on Wealth Alliance Advisory Group's 13F filing for Q2 2023, filed 13 Jul 2023.